⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 22, 2024Alimentary Pharmacology & Therapeutics

Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States

Donghee Kim Karn Wijarnpreecha George Cholankeril Aijaz Ahmed

View at Publisher

Ask AI

Bookmark

Share

Abstract

Recently, a panel of multi-society experts proposed steatotic liver disease (SLD) as an alternative terminology for metabolic dysfunction-associated fatty liver disease (MAFLD) or nonalcoholic fatty liver disease (NAFLD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e6e0a4b6db64358765c9ef https://doi.org/10.1111/apt.18011

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality2024 · 26 citations
2Clinical characteristics and mortality outcomes associated with subtypes of steatotic liver disease in the United States2024
3Importance of the new steatotic liver disease nomenclatureOriginal Research · 2026
4New nomenclature for fatty liver disease2024 · 1 citations
5Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insightsreview · 2025 · 1 citations

More related papers

Steps on the way to a new nomenclature of liver diseases2024
Steatotic Liver Diseases (SLDs): A Review2025
Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology2024

More from Alimentary Pharmacology & Therapeutics

Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population‐Based Cohort StudyTue,
Incidence and Risk Factors for C. difficile Reinfection After Faecal Microbiota Transplantation or Antibiotic TherapyFri,